MedTrace Logo

Can Calcium Ionophore Application Enhance the ICSI Outcomes in Severe Male Factor Infertility?

NCT02992665 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-12-14

No results posted yet for this study

Summary

The purpose of this study is to determine the impact of the use of calcium ionophore on the ICSI outcomes in couples with severe male factor infertility. Investigators conduct a randomized controlled trial on the sibling oocyte to justify the use of calcium ionophore in these cases.

Conditions

  • In Vitro Fertilization
  • Male Factor Infertility

Interventions

DRUG

Ca Ionophore A23187

Sibling oocytes are to be randomized to artificially activated using Calcium ionophore in cases with severely compromized semen parameters

OTHER

Placebo

Placebo is used to control Ca ionophore group

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Osama Abdalmageed · Women health center, Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02992665 on ClinicalTrials.gov